Dianthus Therapeutics | MGTA - PE Price to Earnings


Dianthus Therapeutics reported 3.8 in PE Price to Earnings for its fiscal quarter ending in September of 2024.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
Celltrion 58.97 8.86 Mar/2026
Cspc Pharmaceutical 23.62 0.78 Mar/2026
Deva Holding AS 6.55 2.01 Sep/2023
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 58.35 1.4 Jun/2026
IQVIA Holdings 21.45 2.08 Jun/2026
Kangmei Pharma 1.11K 2.04K Mar/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Laboratorios Farma 18.78 6.64 Dec/2023
Malin Corporation 11.81 0.72 Jun/2023
Moderna 27.22 14.51 Jun/2023
Neuren Pharmaceuticals 72.14 59.86 Dec/2025
Organigram Holdings 12.01 222.99 Mar/2026
Organon & Co 8.32 4.57 Mar/2026
Ovoca Bio 1.83 3.29 Jun/2024
Pharma Mar 16.35 2.78 Jun/2026
Qiagen NV 19.48 1.06 Mar/2026
Revvity 36.47 5.68 Jun/2026
Sartorius 52.99 9.56 Jun/2026
Sino Biopharmaceutical 17.03 0.89 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 34.47 19.86 Jun/2026
Xeris Pharmaceuticals 76.05 2.37K Mar/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026
Zz Pientze Pharmaceu 47.68 1.35 Mar/2026